Timothy P. Walbert - 21 Jan 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: Chairman, President and CEO, Director
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 21 Jan 2022
Net transactions value: -$778,558
Form type: 4
Filing time: 24 Jan 2022, 16:04:46 UTC
Previous filing: 14 Jan 2022
Next filing: 31 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise	$0	+20,336	+3%	$0.000000	694,558	21 Jan 2022	Direct
transaction	HZNP	Ordinary Shares	Tax liability	$778,558	-9,009	-1.3%	$86.42	685,549	21 Jan 2022	Direct
holding	HZNP	Ordinary Shares						107,739	21 Jan 2022	See footnote	F1
holding	HZNP	Ordinary Shares						100,300	21 Jan 2022	See footnote	F2
holding	HZNP	Ordinary Shares						35,603	21 Jan 2022	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Restricted Stock Units (RSUs)	Options Exercise	$0	-20,336	-100%	$0.000000^*	0	21 Jan 2022	Ordinary Shares	20,336		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F2	The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
F3	Each RSU represents a contingent right to receive one ordinary share of the Issuer.